SEC Comment Letter 0000000000-23-011145 to Beam Therapeutics Inc. (BEAM) (CIK 0001745999) (BEAM)
Beam Therapeutics Inc. (BEAM) (CIK 0001745999)
Date: Oct. 12, 2023 · CIK: 0001745999 · Accession: 0000000000-23-011145
AI Filing Summary & Sentiment
File numbers found in text: 001-39208
Letter
United States securities and exchange commission logo October 12, 2023 Terry-Ann Burrell Chief Financial Officer and Treasurer Beam Therapeutics Inc. 238 Main Street Cambridge, MA 02142 Re:Beam Therapeutics Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed February 28, 2023 File No. 001-39208 Dear Terry-Ann Burrell: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
October 12, 2023
Terry-Ann Burrell
Chief Financial Officer and Treasurer
Beam Therapeutics Inc.
238 Main Street
Cambridge, MA 02142
Re:Beam Therapeutics Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed February 28, 2023
File No. 001-39208
Dear Terry-Ann Burrell:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences